John Lewandowski is the founder and CEO of Disease Diagnostic Group (DDG), an organization focused on screening, tracking and diagnosing tropical diseases in the developing world. DDG’s flagship product is the rapid assesment of malaria. Lewandowski has been a managing partner at Lew & Dowski Capital for the past four years and is currently a Ph.D. student at MIT.